Matthew Hamang

745 total citations
7 papers, 75 citations indexed

About

Matthew Hamang is a scholar working on Molecular Biology, Surgery and Oncology. According to data from OpenAlex, Matthew Hamang has authored 7 papers receiving a total of 75 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Surgery and 2 papers in Oncology. Recurrent topics in Matthew Hamang's work include Liver physiology and pathology (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Stress Responses and Cortisol (1 paper). Matthew Hamang is often cited by papers focused on Liver physiology and pathology (2 papers), Pancreatic and Hepatic Oncology Research (1 paper) and Stress Responses and Cortisol (1 paper). Matthew Hamang collaborates with scholars based in United States and China. Matthew Hamang's co-authors include Guirui Yan, Qingqiang Zeng, Armando R. Irizarry, James X. Rong, Yanfei Li, Guoli Dai, Benjamin C. Yaden, Emily White, Verónica García and Nicoletta Bivi and has published in prestigious journals such as PLoS ONE, Journal of Pharmacology and Experimental Therapeutics and Biochemical Pharmacology.

In The Last Decade

Matthew Hamang

6 papers receiving 75 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Hamang United States 5 36 20 11 11 11 7 75
Janaina Da Silva Martins United States 5 35 1.0× 32 1.6× 10 0.9× 31 2.8× 7 0.6× 7 103
Meiheng Sun Hong Kong 5 54 1.5× 27 1.4× 6 0.5× 3 0.3× 5 0.5× 7 113
Yiqun Yang China 5 33 0.9× 5 0.3× 11 1.0× 3 0.3× 18 1.6× 21 95
Changwei Lu China 3 43 1.2× 13 0.7× 6 0.5× 7 0.6× 6 0.5× 3 58
Monica T. Hannani Denmark 3 43 1.2× 15 0.8× 9 0.8× 4 0.4× 17 1.5× 5 97
Ruijun Bai China 6 69 1.9× 20 1.0× 8 0.7× 7 0.6× 48 4.4× 10 120
Melissa M. Formosa Malta 7 31 0.9× 15 0.8× 12 1.1× 3 0.3× 9 0.8× 12 86
Nicholas Wang United States 3 63 1.8× 11 0.6× 6 0.5× 2 0.2× 9 0.8× 8 91
Paulina Stadnik United Kingdom 4 36 1.0× 41 2.0× 41 3.7× 10 0.9× 42 3.8× 5 115
Anisa Gumerova Russia 5 35 1.0× 10 0.5× 10 0.9× 2 0.2× 9 0.8× 20 85

Countries citing papers authored by Matthew Hamang

Since Specialization
Citations

This map shows the geographic impact of Matthew Hamang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Hamang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Hamang more than expected).

Fields of papers citing papers by Matthew Hamang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Hamang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Hamang. The network helps show where Matthew Hamang may publish in the future.

Co-authorship network of co-authors of Matthew Hamang

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Hamang. A scholar is included among the top collaborators of Matthew Hamang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Hamang. Matthew Hamang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Hamang, Matthew, Benjamin C. Yaden, & Guoli Dai. (2023). Gastrointestinal pharmacology activins in liver health and disease. Biochemical Pharmacology. 214. 115668–115668. 4 indexed citations
2.
Hamang, Matthew, Yan Wang, Emily White, et al.. (2023). GDF8 Contributes to Liver Fibrogenesis and Concomitant Skeletal Muscle Wasting. Biomedicines. 11(7). 1909–1909. 1 indexed citations
3.
Heuer, Josef G., Catalina M. Meyer, Hana E. Baker, et al.. (2022). Pharmacological Evaluation of a Pegylated Urocortin-1 Peptide in Experimental Autoimmune Disease Models. Journal of Pharmacology and Experimental Therapeutics. 382(3). 287–298.
4.
Wang, Yan, Matthew Hamang, Verónica García, et al.. (2022). Activin B promotes the initiation and progression of liver fibrosis. Hepatology Communications. 6(10). 2812–2826. 7 indexed citations
5.
Irizarry, Armando R., Guirui Yan, Qingqiang Zeng, et al.. (2017). Defective enamel and bone development in sodium-dependent citrate transporter (NaCT) Slc13a5 deficient mice. PLoS ONE. 12(4). e0175465–e0175465. 40 indexed citations
6.
Okragly, Angela J., Matthew Hamang, Hana E. Baker, et al.. (2016). Elevated levels of Interleukin (IL)-33 induce bone pathology but absence of IL-33 does not negatively impact normal bone homeostasis. Cytokine. 79. 66–73. 9 indexed citations
7.
Li, Yanfei, Matthew Hamang, Nicoletta Bivi, et al.. (2016). Time course of disassociation of bone formation signals with bone mass and bone strength in sclerostin antibody treated ovariectomized rats. Bone. 97. 20–28. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026